Glaxosmithkline Pharmaceuticals consolidated net profit declines 72.22% in the December 2023 quarter
Sales rise 0.37% to Rs 805.26 crore
Net profit of Glaxosmithkline Pharmaceuticals declined 72.22% to Rs 45.72 crore in the quarter ended December 2023 as against Rs 164.56 crore during the previous quarter ended December 2022. Sales rose 0.37% to Rs 805.26 crore in the quarter ended December 2023 as against Rs 802.30 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales805.26802.30 0 OPM %27.0828.51 -PBDT245.85252.03 -2 PBT228.74235.62 -3 NP45.72164.56 -72Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2024 | 7:36 AM IST